Abstract
Investigators have scientific, ethical, and personal reasons for publishing the results of their clinical trials. The conduct and analysis of the trial should be done in a transparent manner, and the outcomes/endpoints that were determined a priori must be reported, regardless of the results. The conduct and analysis of the trial should be done in a transparent manner and analyses should be done on the outcomes that were decided upon a priori. A number of resources and checklists are available for ensuring all of the necessary components of the write-up are included in the manuscript. The trial results should be published, irrespective of the findings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smith TL, et al. Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center. J Clin Oncol. 1996;14(1):287–95.
Estey E, et al. Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep. 1986;70(9):1105–15.
Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990;263(10):1385–9.
Easterbrook PJ, et al. Publication bias in clinical research. Lancet. 1991;337(8746):867–72.
Dickersin K, et al. Publication bias and clinical trials. Control Clin Trials. 1987;8(4):343–53.
Callaham ML, et al. Positive-outcome bias and other limitations in the outcome of research abstracts submitted to a scientific meeting. JAMA. 1998;280(3):254–7.
Krzyzanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA. 2003;290(4):495–501.
Dickersin K, Rennie D. Registering clinical trials. JAMA. 2003;290(4):516–23.
Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53(2):207–16.
Savitz DA. Failure to publish results of epidemiologic studies is unethical. Epidemiology. 2000;11(3):361–3.
Clinical Trials.gov. 2011. Available from: http://clinicaltrials.gov/. Cited 3 Oct 2012.
Congress t.U.S. Food and Drug Administration Act of 2007. Congress t.U.S., editor 2007.
Clinical trial registration: a statement from the International Committee of Medical Journal editors. Available from: http://www.icmje.org/clin_trial.pdf. Cited 3 Oct 2012.
Congress t.U.S. Trial and Experimental Studies Transparency Act of 2012. 2012.
Drazen JM. Transparency for clinical trials–the TEST Act. N Engl J Med. 2012;367(9):863–4.
GlaxoSmithKline. Public disclosure of clinical research. 2012. Available from: http://www.gsk.com/policies/GSK-on-disclosure-of-clinical-trial-information.pdf. 3 Oct 2012
Merck. Merck guidelines for publication of clinical trials and related works. 2013. Available from: http://www.merck.com/research/discovery-and-development/clinical-development/Merck-Guidelines-for-Publication-of-Clinical-Trials-and-Related-Works.pdf. Accessed 11 October 2013.
Davidoff F, et al. Sponsorship, authorship, and accountability. JAMA. 2001;286(10):1232–4.
I.C.o.M.J., editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Ethical Considerations in the Conduct and Reporting of Research: Authorship and Contributorship. 2009. Available from: http://www.icmje.org/ethical_1author.html. 3 Oct 2012.
Blum JA, et al. Requirements and definitions in conflict of interest policies of medical journals. JAMA. 2009;302(20):2230–4.
Amdur RJ, Biddle C. Institutional review board approval and publication of human research results. JAMA. 1997;277(11):909–14.
Ruiz-Canela M, et al. Informed consent and approval by institutional review boards in published reports on clinical trials. N Engl J Med. 1999;340(14):1114–5.
Schroter S, et al. Reporting ethics committee approval and patient consent by study design in five general medical journals. J Med Ethics. 2006;32(12):718–23.
N.I.o. Health, editor. NIH policy for data and safety monitoring. 1998. Available from: http://grants.nih.gov/grants/guide/notice-files/not98-084.html. Accessed 11 October 2013.
C.f.B.E.a.R. Food and Drug Administration, Center for Drug Evaluation and Research, Center for Devices and Radiological Health, editors. Guidance for clinical trial sponsors. Establishment and operation of clinical trial data monitoring. 2006. Available from: http://www.fda.gov/downloads/Regulatoryinformation/Guidances/ucm127073.pdf. Accessed 11 October 2013.
Drazen JM, Wood AJ. Don’t mess with the DSMB. N Engl J Med. 2010;363(5):477–8.
Mathieu S, et al. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA. 2009;302(9):977–84.
Al-Marzouki S, et al. Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet. Lancet. 2008;372(9634):201.
Wang R, et al. Statistics in medicine–reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189–94.
Trials C.S.o.R. CONSORT 2010 checklist of information to include when reporting a randomised trial. 2010. Available from: www.consort-statement.org/index.aspx?o=2965.
I.C.o.M.J., editor. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Manuscript Preparation and Submission: Preparing a Manuscript for Submission to a Biomedical Journal. 2009. Available from: http://www.icmje.org/manuscript_1prepare.html. 4 Oct 2012.
Devereaux PJ, et al. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol. 2004;57(12):1232–6.
Pocock SJ, Travison TG, Wruck LM. How to interpret figures in reports of clinical trials. BMJ. 2008;336(7654):1166–9.
Wainer H. How to display data badly. Am Stat. 1984;38:137–47.
Kelleher C, Wagener T. Ten guidelines for effective data visualization in scientific publications. Environ Model Software. 2011;26:822–7.
Freeman JV, Walters S, Campbell MJ. How to display data. How to series. 1st ed. Wiley, John & Sons, Oxford, UK, Incorporated; 2008.
Das N, Panjabi M. Plagiarism: why is it such a big issue for medical writers? Perspect Clin Res. 2011;2(2):67–71.
Hopewell S, et al. Time to publication for results of clinical trials. Cochrane Database Syst Rev. 2007;2:MR000011.
Ross JS, et al. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ. 2012;344:d7292.
Hrynaszkiewicz I, et al. Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. BMJ. 2010;340:c181.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Orandi, B.J., Freischlag, J.A., Malas, M. (2014). Publishing a Clinical Trial. In: Pawlik, T., Sosa, J. (eds) Success in Academic Surgery: Clinical Trials. Success in Academic Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4679-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4679-7_9
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4678-0
Online ISBN: 978-1-4471-4679-7
eBook Packages: MedicineMedicine (R0)